E-LIB Suche - Ergebnisse für: Delimpasi, Sosana

1

Ixazomib plus daratumumab and dexamethasone: Final analysis..:

Delimpasi, Sosana ; Dimopoulos, Meletios A. ; Straub, Jan...
American Journal of Hematology. 99 (2024) 9 - p. 1746-1756 , 2024

Link: https://doi.org/10.1002/..

2

Central nervous system multiple myeloma: A real‐world multi..:

Katodritou, Eirini ; Dalampira, Dimitra ; Delimpasi, Sosana...
American Journal of Hematology. 99 (2024) 10 - p. 1897-1905 , 2024

Link: https://doi.org/10.1002/..

3

An open-label phase 2 study treating patients with first or..:

Perrot, Aurore ; Delimpasi, Sosana ; Spanoudakis, Emmanouil...
Leukemia & Lymphoma. 65 (2024) 6 - p. 833-842 , 2024

Link: https://doi.org/10.1080/..

4

A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomid..:

Dimopoulos, Meletios-Athanasios A. ; Coriu, Daniel ; Delimpasi, Sosana...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

5

Efficacy and safety of daratumumab with ixazomib and dexame..:

Terpos, Evangelos ; Ntanasis‐Stathopoulos, Ioannis ; Gavriatopoulou, Maria...
American Journal of Hematology. 99 (2024) 3 - p. 396-407 , 2024

Link: https://doi.org/10.1002/..

6

P-456 Survey on real world quality of life (QoL) issues rel..:

Bristogiannis, Sotirios ; Khwaja, Jahanzaib ; Foard, Darren...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S291 , 2023

Link: https://doi.org/10.1016/..

7

P-117 A prognostic score based on age, eGFR (CKD-EPI), perf..:

Katodritou, Eirini ; Kastritis, Efstathios ; Dalampira, Dimitra...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S99-S100 , 2023

Link: https://doi.org/10.1016/..

8

P-457 Waldenstrom's Macroglobulinaemia (WM) patients' onlin..:

Bristogiannis, Sotirios ; Khwaja, Jahanzaib ; Tohidi-Esfahani, Ibrahim...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S291-S292 , 2023

Link: https://doi.org/10.1016/..

9

P-454 Patients views on the relevance of quality of life (Q..:

Bristogiannis, Sotirios ; Khwaja, Jahanzaib ; Foard, Darren...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S290 , 2023

Link: https://doi.org/10.1016/..

10

P-319 Efficacy and safety of daratumumab with ixazomib and ..:

Terpos, Evangelos ; Ntanasis-Stathopoulos, Ioannis ; Gavriatopoulou, Maria...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213-S214 , 2023

Link: https://doi.org/10.1016/..

11

P-455 Survey of multiple myeloma (MM) patients and healthca..:

Bristogiannis, Sotirios ; Lecat, Catherine SY. ; Mehta, Dipal...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S290-S291 , 2023

Link: https://doi.org/10.1016/..

12

Does the Simultaneous Introduction of Several Pharmaceutica..:

Petrakis, Ioannis ; Kontogiorgis, Christos ; Nena, Evangelia...
Cancers. 15 (2023) 24 - p. 5846 , 2023

Link: https://doi.org/10.3390/..

13

P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS W..:

Terpos, Evangelos ; Gavriatopoulou, Maria ; Katodritou, Eirini...
HemaSphere. 7 (2023) S3 - p. e43614c0 , 2023

Link: https://doi.org/10.1097/..

14

S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING TH..:

Dimopoulos, Meletios A. ; Hungria, Vania ; Radinoff, Atanas...
HemaSphere. 7 (2023) S3 - p. e072005a , 2023

Link: https://doi.org/10.1097/..

15

Improved survival of patients with primary plasma cell leuk..:

Katodritou, Eirini ; Kastritis, Efstathios ; Dalampira, Dimitra...
American Journal of Hematology. 98 (2023) 5 - p. 730-738 , 2023

Link: https://doi.org/10.1002/..